Similar articles for PMID: 22072706

Year	Number of Results
1990	2
1991	3
1992	2
1993	1
1994	1
1995	2
1996	1
1997	2
1999	1
2000	2
2001	1
2002	1
2003	4
2004	3
2005	1
2006	3
2007	1
2008	3
2009	4
2010	7
2011	12
2012	12
2013	19
2014	16
2015	22
2016	36
2017	25
2018	23
2019	18
2020	13
2021	16
2022	12
2023	3
2024	0

1

PET with the 89Zr-labeled transforming growth factor-β antibody fresolimumab in tumor models.

Oude Munnink TH, Arjaans ME, Timmer-Bosscha H, Schröder CP, Hesselink JW, Vedelaar SR, Walenkamp AM, Reiss M, Gregory RC, Lub-de Hooge MN, de Vries EG. Oude Munnink TH, et al. J Nucl Med. 2011 Dec;52(12):2001-8. doi: 10.2967/jnumed.111.092809. Epub 2011 Nov 9. J Nucl Med. 2011. PMID: 22072706 Free article.

2

TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with 89Zr-Fresolimumab PET.

den Hollander MW, Bensch F, Glaudemans AW, Oude Munnink TH, Enting RH, den Dunnen WF, Heesters MA, Kruyt FA, Lub-de Hooge MN, Cees de Groot J, Pearlberg J, Gietema JA, de Vries EG, Walenkamp AM. den Hollander MW, et al. J Nucl Med. 2015 Sep;56(9):1310-4. doi: 10.2967/jnumed.115.154401. Epub 2015 Jul 1. J Nucl Med. 2015. PMID: 26135113 Free article. Clinical Trial.

3

Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas.

Bhattacharyya S, Kurdziel K, Wei L, Riffle L, Kaur G, Hill GC, Jacobs PM, Tatum JL, Doroshow JH, Kalen JD. Bhattacharyya S, et al. Nucl Med Biol. 2013 May;40(4):451-7. doi: 10.1016/j.nucmedbio.2013.01.007. Epub 2013 Feb 27. Nucl Med Biol. 2013. PMID: 23454247 Free PMC article.

4

Placental growth factor (PlGF)-specific uptake in tumor microenvironment of 89Zr-labeled PlGF antibody RO5323441.

Oude Munnink TH, Tamas KR, Lub-de Hooge MN, Vedelaar SR, Timmer-Bosscha H, Walenkamp AM, Weidner KM, Herting F, Tessier J, de Vries EG. Oude Munnink TH, et al. J Nucl Med. 2013 Jun;54(6):929-35. doi: 10.2967/jnumed.112.112086. Epub 2013 Apr 26. J Nucl Med. 2013. PMID: 23625582 Free article.

5

Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.

Rylova SN, Del Pozzo L, Klingeberg C, Tönnesmann R, Illert AL, Meyer PT, Maecke HR, Holland JP. Rylova SN, et al. J Nucl Med. 2016 Jan;57(1):96-102. doi: 10.2967/jnumed.115.162735. Epub 2015 Oct 29. J Nucl Med. 2016. PMID: 26514172 Free article.

6

⁸⁹Zr-Labeled fresolimumab (human anti-transforming growth factor-β monoclonal antibody).

Chopra A. Chopra A. 2011 Dec 13 [updated 2012 Jan 26]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2011 Dec 13 [updated 2012 Jan 26]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 22299190 Free Books & Documents. Review.

7

Preclinical evaluation of ⁸⁹Zr-labeled human antitransferrin receptor monoclonal antibody as a PET probe using a pancreatic cancer mouse model.

Sugyo A, Tsuji AB, Sudo H, Nagatsu K, Koizumi M, Ukai Y, Kurosawa G, Zhang MR, Kurosawa Y, Saga T. Sugyo A, et al. Nucl Med Commun. 2015 Mar;36(3):286-94. doi: 10.1097/MNM.0000000000000245. Nucl Med Commun. 2015. PMID: 25460304

8

Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.

Verel I, Visser GW, Boellaard R, Boerman OC, van Eerd J, Snow GB, Lammertsma AA, van Dongen GA. Verel I, et al. J Nucl Med. 2003 Oct;44(10):1663-70. J Nucl Med. 2003. PMID: 14530484 Free article.

9

89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.

Verel I, Visser GW, Boellaard R, Stigter-van Walsum M, Snow GB, van Dongen GA. Verel I, et al. J Nucl Med. 2003 Aug;44(8):1271-81. J Nucl Med. 2003. PMID: 12902418 Free article.

10

⁸⁹Zr-DFO-AMG102 Immuno-PET to Determine Local Hepatocyte Growth Factor Protein Levels in Tumors for Enhanced Patient Selection.

Price EW, Carnazza KE, Carlin SD, Cho A, Edwards KJ, Sevak KK, Glaser JM, de Stanchina E, Janjigian YY, Lewis JS. Price EW, et al. J Nucl Med. 2017 Sep;58(9):1386-1394. doi: 10.2967/jnumed.116.187310. Epub 2017 Mar 9. J Nucl Med. 2017. PMID: 28280216 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

233 results

Results by year